Real-time enrollment status for this nausea and vomiting clinical trial
Current Status
Recruiting
Checked: August 29, 2026 at 12:42 AM UTC
| NCT Number | NCT07446439 |
| Recruiting Status | Recruiting |
| Condition | Nausea and Vomiting |
| Phase | PHASE3 |
| Target Enrollment | 280 participants |
| Active Locations | 10 sites in the US |
| Sponsor | Vanda Pharmaceuticals |
| Last Updated on CT.gov | April 20, 2026 (Apr 20, 2026) |
As of August 29, 2026: Clinical trial NCT07446439 is currently recruiting participants. This phase3 study for nausea and vomiting is actively seeking new participants at 10 locations across the United States. The study is sponsored by Vanda Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07446439 is actively recruiting participants as of August 29, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 10 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07446439 was last updated Apr 20, 2026 (April 20, 2026). HelloStudys verifies this status automatically.